Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinando Squitieri

Showing results (101-110 of 147) with videos related to

Pageof 15
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 15, 2020
Tracing the mutated HTT and haplotype of the African ancestor who spread Huntington disease into the Middle EastFerdinando Squitieri, Tommaso Mazza, Sabrina Maffi, et al.
Mechanisms of Ageing and Development|November 18, 2005
Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutationFerdinando Squitieri, Milena Cannella, Gianluca Sgarbi, et al.
Frontiers in Psychology|December 19, 2022
Diagnostic properties of the Frontal Assessment Battery (FAB) in Huntington's diseaseFederica Solca, Edoardo Nicolò Aiello, Simone Migliore, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 22, 2019
Defining pediatric huntington disease: Time to abandon the term Juvenile Huntington Disease?Oliver W J Quarrell, Martha A Nance, Peg Nopoulos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 24, 2015
Huntingtin Haplotypes Provide Prioritized Target Panels for Allele-specific Silencing in Huntington Disease Patients of European AncestryChris Kay, Jennifer A Collins, Niels H Skotte, et al.
Journal of Personalized Medicine|January 21, 2022
"Spazio Huntington": Tracing the Early Motor, Cognitive and Behavioral Profiles of Kids with Proven Pediatric Huntington Disease and Expanded Mutations > 80 CAG RepeatsFederica Graziola, Sabrina Maffi, Melissa Grasso, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 17, 2021
Compensating for verbal-motor deficits in neuropsychological assessment in movement disorders: sensitivity and specificity of the ECAS in Parkinson's and Huntington's diseasesLaura Carelli, Federica Solca, Simone Migliore, et al.
Annals of Neurology|February 9, 2002
Localization of autosomal recessive early-onset parkinsonism to chromosome 1p36 (PARK7) in an independent datasetVincenzo Bonifati, Guido J Breedveld, Ferdinando Squitieri, et al.
International Journal of Molecular Sciences|February 2, 2021
Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived CellsTheo Battista, Gianmarco Pascarella, David Sasah Staid, et al.
The Lancet. Neurology|December 20, 2018
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging studyRalf Reilmann, Andrew McGarry, Igor D Grachev, et al.
Pageof 15

Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 15, 2020
Tracing the mutated HTT and haplotype of the African ancestor who spread Huntington disease into the Middle EastFerdinando Squitieri, Tommaso Mazza, Sabrina Maffi, et al.
Mechanisms of Ageing and Development|November 18, 2005
Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutationFerdinando Squitieri, Milena Cannella, Gianluca Sgarbi, et al.
Frontiers in Psychology|December 19, 2022
Diagnostic properties of the Frontal Assessment Battery (FAB) in Huntington's diseaseFederica Solca, Edoardo Nicolò Aiello, Simone Migliore, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 22, 2019
Defining pediatric huntington disease: Time to abandon the term Juvenile Huntington Disease?Oliver W J Quarrell, Martha A Nance, Peg Nopoulos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 24, 2015
Huntingtin Haplotypes Provide Prioritized Target Panels for Allele-specific Silencing in Huntington Disease Patients of European AncestryChris Kay, Jennifer A Collins, Niels H Skotte, et al.
Journal of Personalized Medicine|January 21, 2022
"Spazio Huntington": Tracing the Early Motor, Cognitive and Behavioral Profiles of Kids with Proven Pediatric Huntington Disease and Expanded Mutations > 80 CAG RepeatsFederica Graziola, Sabrina Maffi, Melissa Grasso, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 17, 2021
Compensating for verbal-motor deficits in neuropsychological assessment in movement disorders: sensitivity and specificity of the ECAS in Parkinson's and Huntington's diseasesLaura Carelli, Federica Solca, Simone Migliore, et al.
Annals of Neurology|February 9, 2002
Localization of autosomal recessive early-onset parkinsonism to chromosome 1p36 (PARK7) in an independent datasetVincenzo Bonifati, Guido J Breedveld, Ferdinando Squitieri, et al.
International Journal of Molecular Sciences|February 2, 2021
Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived CellsTheo Battista, Gianmarco Pascarella, David Sasah Staid, et al.
The Lancet. Neurology|December 20, 2018
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging studyRalf Reilmann, Andrew McGarry, Igor D Grachev, et al.
Pageof 15